Synergistic regulation of gut microbiota and metabolites by breast milk and probiotics in the prevention of neonatal necrotizing enterocolitis: mechanisms and prospects
Open Access
- 1 April 2026
- journal article
- review article
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 15 (4) , 154
Abstract
Necrotizing enterocolitis (NEC) remains one of the most devastating gastrointestinal emergencies in preterm infants and is associated with high morbidity, mortality, and long-term complications. Increasing evidence suggests that breast milk and probiotics may act synergistically to reduce NEC risk by modulating the intestinal microbiota, its metabolites, and host immune responses. As the optimal nutritional source for preterm infants, breast milk provides a wide range of bioactive components, including human milk oligosaccharides (HMOs), lactoferrin, and immunoglobulins, which promote intestinal maturation, strengthen epithelial barrier function, inhibit pathogen colonization, and support immune development. Probiotics further complement these protective effects by enhancing the colonization of beneficial bacteria, suppressing the overgrowth of potential pathogens, improving barrier integrity, and regulating inflammatory signaling. In this context, microbial metabolites emerge as critical proximal mediators linking microbial composition to host protection. Among them, short-chain fatty acids (SCFAs) and tryptophan-derived indole metabolites play essential roles in maintaining intestinal homeostasis, promoting mucosal integrity, and modulating immune tolerance. Therefore, the preventive effects of breast milk and probiotics should be understood not only as independent benefits, but also as coordinated ecological and metabolic regulation of the immature gut. A better understanding of these interactions may provide a mechanistic basis for developing personalized and evidence-based strategies for NEC prevention in preterm infants.Keywords
This publication has 155 references indexed in Scilit:
- Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestineBeneficial Microbes, 2016
- Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat modelBeneficial Microbes, 2016
- Roles of nitric oxide and intestinal microbiota in the pathogenesis of necrotizing enterocolitisJournal of Pediatric Surgery, 2016
- Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1β-Induced Inflammation: A Transcription Profiling AnalysisPLOS ONE, 2015
- Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formulaPediatric Research, 2014
- Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled TrialPediatrics, 2013
- Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infantsMicrobiome, 2013
- 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitisThe ISME Journal, 2009
- Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight NeonatesThe Journal of Pediatrics, 2005
- Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight InfantsPediatrics, 2005